JDRF 2011 Annual Silicon Valley Summit: FDA Reform: How Can We Remain Competitive While Protecting Public Safety
Please join JDRF, the Stanford School of Medicine and BayBio for a conversation among stakeholders to consider constructive means to improve the FDA approval process, which has become a serious impediment to investment in US medical device and biotech companies and for those companies to market products and therapies in the US.
Mark Fischer-Colbrie, President and CEO, Labcyte Inc.
Emory Anderson, President and CEO, Intuity Medical
Michael J. Billig, Co-Founder and CEO, Experien Group
Dr. Bruce Buckingham, Professor, Stanford School of Medicine
John F. Maroney, General Partner, Delphi Ventures
Michelle Rohrer, Vice President Regulatory Affairs, Genentech